Information Center
Congratulations! Xinkanghe Biotechnology has been selected as a "Unicorn" cultivation enterprise in Suzhou for the year 2022.
Release time:
2023-01-16 19:07
Today, Suzhou City announced the selection list for the 2022 "Unicorn" cultivation enterprises. Suzhou Xinkanghe Biomedical Technology Co., Ltd. was successfully selected due to its outstanding innovation capabilities and significant potential to meet the clinical needs of patients in the future!
The Suzhou "Unicorn" cultivation plan is the first national "Unicorn" cultivation plan launched by the Suzhou municipal government in 2018. The goal is to deeply implement the innovation-driven development strategy, accelerate the improvement of the cultivation system for innovative enterprises, cultivate and expand clusters of innovative enterprises, and create peak enterprises in technological innovation and iconic industries, serving as an important barometer for the development of the new economy.
With this selection, Xinkanghe Biomedical Company has successfully entered the ranks of innovative enterprises with independent innovation, high growth, and competitive advantages, possessing the potential to accelerate its growth into a unicorn enterprise. This recognition as a "Unicorn" cultivation enterprise not only affirms Xinkanghe's positioning as a "global new" and "best in class" antibody project capability but also marks the beginning of a new journey for the company's development.
Unicorn, innovation
Related News
Beijing Address: A203, Zhongguancun Biomedical Park, No.5, Development Road, Haidian District, Beijing
Zhejiang Address: Floor 8, Building 7, Dongsheng Huigu, 1299 Kehai Avenue, Keqiao District, Shaoxing City, Zhejiang Province
Contact Phone:010-82176552
E-mail:hr@kanovabiopharma.com